Analyst Consensus ?
ConsensusBuy41 ratings
Bullish2561.0%
Neutral1536.6%
Bearish12.4%
Synchrony Financial · SYF · FY2026 Q3 · Calendar Q4 2026
Synchrony holds guidance as partnerships and AI support growth
The quarter supports a constructive but qualified view: partner expansion, embedded financing, and AI initiatives broaden Synchrony's growth avenues, but sustained earnings growth depends on containing payment-rate, expense, and credit pressures.
Reported Before market openNYSEFinancial Services
$24.16B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $2.42
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $3.81B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-0.9%
Event window
SPY move
+0.3%
Same window
Abnormal move
-1.2%
Stock minus SPY
Volume
0.5×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
SYFSPY benchmark
Ask FN2 about SYF FY2026 Q3
Transcript, numbers and history already loaded
What drove SYF's -0.9% move after FY2026 Q3 earnings?What changed in SYF's guidance and outlook in FY2026 Q3?Give me the bull and bear case for SYF after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current quarter added CareCredit Pay Later, Stripe and Vetspire integrations, and OpenAI-related initiatives to the growth narrative. Management maintained guidance, while higher payment rates, RSA, technology spending, and reserve uncertainty remained the main near-term constraints.
Guidance delta
Maintained; management positioned full-year EPS guidance at the high end of its prior range.
Key takeaways
- Purchase volume reached a record level, supported by broad platform growth and new program launches.
- CareCredit Pay Later and integrations with Stripe and Vetspire extend embedded-financing opportunities.
- OpenAI and agentic-commerce initiatives broaden the technology-led growth agenda, while payment rates and expenses weigh on near-term efficiency.
Management priorities
- Expand CareCredit Pay Later across additional health-care locations.
- Deepen Stripe and Vetspire checkout integrations and continue partnership development.
- Scale AI, digital-wallet, and agentic-commerce capabilities.
Follow SYF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$73.22Current
$40Low
$73.17Average
$104High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 20, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 12, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 12, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 6, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 1, 2026 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 25, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 22, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 22, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 22, 2026 |
| HSBC | Buy | Buy | Maintain | Jul 13, 2026 |
| Truist Securities | Hold | Hold | Maintain | Apr 23, 2026 |
| BTIG | Neutral | Buy | Downgrade | Apr 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 22, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jan 2, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Sep 25, 2025 |
| B of A Securities | Buy | Buy | Maintain | Sep 11, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 2, 2025 |
| Compass Point | Neutral | Buy | Downgrade | Jan 28, 2025 |
| Jefferies | Buy | Buy | Maintain | Oct 17, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 17, 2024 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 18, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Mar 6, 2024 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jan 24, 2024 |
| Piper Sandler | Overweight | Overweight | Maintain | Jan 24, 2024 |
| Citigroup | Buy | Buy | Maintain | Jan 16, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 18, 2023 |
| Seaport Global | Buy | Buy | Maintain | Aug 30, 2021 |
| Nomura | Neutral | Neutral | Maintain | Apr 14, 2020 |
| CFRA | Strong Sell | Sell | Maintain | Apr 3, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Jan 30, 2019 |
| Buckingham | Buy | Buy | Maintain | Mar 14, 2018 |
| Guggenheim | Neutral | Buy | Downgrade | May 3, 2017 |
| Wedbush | Neutral | Outperform | Downgrade | Dec 7, 2016 |
| Macquarie | Neutral | Neutral | Maintain | May 11, 2016 |
| DA Davidson | Buy | Buy | Maintain | Jan 13, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Nov 23, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Nov 23, 2015 |
| Buckingham Research | Buy | Buy | Maintain | Aug 26, 2015 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2015 |
| Bernstein | Outperform | Outperform | Maintain | May 6, 2015 |
| BTIG Research | Buy | Neutral | Upgrade | Apr 20, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $73.22. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $83 | $72.8 | +13.4% | Oct 12, 2026 |
| BMO Capital | Andrew Bauch | $81 | $73.72 | +10.6% | Oct 8, 2026 |
| Seaport Global | Analyst unavailable | $93 | $71.41 | +27.0% | Oct 7, 2026 |
| UBS | Analyst unavailable | $81 | $71.77 | +10.6% | Oct 5, 2026 |
| Wolfe Research | Darrin Peller | $90 | $80.02 | +22.9% | Aug 25, 2026 |
| UBS | Analyst unavailable | $87 | $77.56 | +18.8% | Aug 3, 2026 |
| Deutsche Bank | Analyst unavailable | $104 | $71.88 | +42.0% | Jul 22, 2026 |
| RBC Capital | Jon Arfstrom | $80 | $72.21 | +9.3% | Jul 22, 2026 |
| Robert W. Baird | Analyst unavailable | $90 | $72.21 | +22.9% | Jul 22, 2026 |
| Wells Fargo | Analyst unavailable | $88 | $72.21 | +20.2% | Jul 22, 2026 |
| HSBC | Analyst unavailable | $97 | $72.44 | +32.5% | Jul 13, 2026 |
| Loop Capital Markets | Analyst unavailable | $81 | $72 | +10.6% | May 21, 2026 |
| Truist Financial | Brian Foran | $82 | $78.69 | +12.0% | Apr 23, 2026 |
| Morgan Stanley | Analyst unavailable | $84 | $77.63 | +14.7% | Apr 21, 2026 |
| Robert W. Baird | David George | $83 | $71.11 | +13.4% | Feb 13, 2026 |
| UBS | Analyst unavailable | $82 | $74.82 | +12.0% | Feb 4, 2026 |
| Truist Financial | Analyst unavailable | $84 | $73.17 | +14.7% | Jan 29, 2026 |
| RBC Capital | Jon Arfstrom | $85 | $74.49 | +16.1% | Jan 28, 2026 |
| Compass Point | Dominick Gabriele | $96 | $73 | +31.1% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $93 | $73 | +27.0% | Jan 28, 2026 |
| BTIG | Vincent Caintic | $96 | $73 | +31.1% | Jan 27, 2026 |
| RBC Capital | Jon Arfstrom | $91 | $79.53 | +24.3% | Jan 12, 2026 |
| UBS | Analyst unavailable | $86 | $86.89 | +17.5% | Jan 12, 2026 |
| Evercore ISI | Analyst unavailable | $97 | $87.47 | +32.5% | Jan 6, 2026 |
| Goldman Sachs | Analyst unavailable | $98 | $87.16 | +33.9% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $101 | $86.74 | +37.9% | Jan 6, 2026 |
| Wells Fargo | Donald Fandetti | $100 | $86.94 | +36.6% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $92 | $85.6 | +25.7% | Dec 22, 2025 |
| Wells Fargo | Donald Fandetti | $95 | $83.39 | +29.8% | Dec 17, 2025 |
| Morgan Stanley | Analyst unavailable | $86 | $83.88 | +17.5% | Dec 16, 2025 |
| Robert W. Baird | Analyst unavailable | $82 | $80.4 | +12.0% | Dec 5, 2025 |
| Truist Financial | Analyst unavailable | $78 | $71.83 | +6.5% | Oct 17, 2025 |
| Wells Fargo | Analyst unavailable | $85 | $72.32 | +16.1% | Oct 16, 2025 |
| HSBC | Analyst unavailable | $81 | $70.99 | +10.6% | Oct 10, 2025 |
| UBS | Erika Najarian | $79 | $70.48 | +7.9% | Oct 7, 2025 |
| Barclays | Analyst unavailable | $83 | $71.23 | +13.4% | Oct 6, 2025 |
| Evercore ISI | Analyst unavailable | $84 | $73.32 | +14.7% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $82 | $74.54 | +12.0% | Sep 29, 2025 |
| Barclays | Terry Ma | $80 | $70.66 | +9.3% | Jul 23, 2025 |
| Seaport Global | Analyst unavailable | $76 | $64.74 | +3.8% | Jun 24, 2025 |
| Truist Financial | Brian Foran | $68 | $59.84 | -7.1% | Jun 13, 2025 |
| Morgan Stanley | Jeff Adelson | $40 | $56.52 | -45.4% | Oct 17, 2024 |
| RBC Capital | Jon Arfstrom | $62 | $56.52 | -15.3% | Oct 17, 2024 |
| Robert W. Baird | Brennan Crowley | $62 | $56.52 | -15.3% | Oct 17, 2024 |
| Wells Fargo | Donald Fandetti | $60 | $56.52 | -18.0% | Oct 17, 2024 |
| Deutsche Bank | Mark DeVries | $68 | $56.52 | -7.1% | Oct 17, 2024 |
| Bank of America Securities | Mihir Bhatia | $61 | $55.47 | -16.7% | Oct 16, 2024 |
| Bank of America Securities | Mihir Bhatia | $54 | $45.76 | -26.2% | Aug 9, 2024 |
| Wells Fargo | Donald Fandetti | $53 | $52.22 | -27.6% | Jul 18, 2024 |
| Barclays | Terry Ma | $49 | $52.22 | -33.1% | Jul 18, 2024 |
| Compass Point | David Rochester | $56 | $50.72 | -23.5% | Jul 16, 2024 |
| JMP Securities | David Scharf | $60 | $50.72 | -18.0% | Jul 16, 2024 |
| Robert W. Baird | Brennan Crowley | $56 | $44.23 | -23.5% | Jun 27, 2024 |
| Goldman Sachs | Ryan Nash | $51 | $44 | -30.3% | Jun 10, 2024 |
| Capital One Financial | James Fotheringham | $41 | $44.34 | -44.0% | Apr 25, 2024 |
| BMO Capital | James Fotheringham | $41 | $45.02 | -44.0% | Apr 25, 2024 |
| RBC Capital | Jon Arfstrom | $47 | $45.02 | -35.8% | Apr 25, 2024 |
| Wolfe Research | Bill Carcache | $50 | $41.21 | -31.7% | Apr 4, 2024 |
| Goldman Sachs | Analyst unavailable | $45 | $40.7 | -38.5% | Apr 19, 2022 |
| BMO Capital | Analyst unavailable | $52 | $40.8 | -29.0% | Apr 19, 2022 |
| Wolfe Research | Bill Carcache | $38 | $35.65 | -48.1% | Apr 7, 2022 |
| Piper Sandler | Kevin Barker | $49 | $35.77 | -33.1% | Apr 6, 2022 |
| JMP Securities | David Scharf | $50 | $42.38 | -31.7% | Jan 31, 2022 |
| Stephens | Vincent Caintic | $54 | $42.38 | -26.2% | Jan 31, 2022 |
| Seaport Global | Bill Ryan | $54 | $42.38 | -26.2% | Jan 31, 2022 |
| RBC Capital | Jon Arfstrom | $60 | $41.21 | -18.0% | Jan 28, 2022 |
| Barclays | Mark Devries | $64 | $48.06 | -12.6% | Jan 10, 2022 |
| Jefferies | John Hecht | $60 | $46.68 | -18.0% | Jan 5, 2022 |
| Citigroup | Arren Cyganovich | $59 | $46.22 | -19.4% | Oct 29, 2021 |
| UBS | Eric Wasserstrom | $49 | $46.83 | -33.1% | Jul 14, 2021 |
Track every rating change on SYF the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationSynchrony Financial, along with its various subsidiaries, functions as a leading provider of consumer financial services across the United States. The company offers a comprehensive range of credit products, encompassing diverse credit card options such as private label, co-branded, and general-purpose cards, alongside commercial credit solutions and consumer installment loans for both short and long durations. Additionally, Synchrony provides consumer banking services, including a variety of deposit products like certificates of deposit, individual retirement accounts, money market accounts, and savings accounts. These are made available to both individual consumers and commercial entities, with deposits also accepted via external securities brokerage firms. Beyond core credit and banking, Synchrony extends debt cancellation programs to its credit card clientele through online, mobile, and direct mail channels.…
Historical context
All SYF earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| SYF-PA Synchrony Financial | FY2026 Q3 · Calendar Q4 2026 | — | — | Synchrony reaffirms $9.50 EPS outlook as digital and AI initiatives expand |
| SYF-PB Synchrony Financial | FY2026 Q3 · Calendar Q4 2026 | — | — | Synchrony holds top-end EPS guidance as digital initiatives expand |
| WRB W. R. Berkley Corporation | FY2026 Q3 · Calendar Q4 2026 | +1.7% | -0.7% | W.R. Berkley pairs record underwriting profit with selective growth |
| WRB-PG W.R. Berkley Corporation 4.25% | FY2026 Q3 · Calendar Q4 2026 | +1.7% | — | W.R. Berkley: Strong underwriting offsets reinsurance pressure |
| WRB-PH W.R. Berkley Corporation 4.125% | FY2026 Q3 · Calendar Q4 2026 | +1.7% | — | W.R. Berkley: Strong underwriting, deliberate reinsurance pullback |
| WRB-PE W. R. Berkley Corporation 5.70% SB DB 2058 | FY2026 Q3 · Calendar Q4 2026 | +1.7% | — | W.R. Berkley: Strong underwriting, disciplined growth and new AI risks |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the SYF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-20T15:03:18.831342+00:00
- FN2 earnings calendar · 2026-10-20T01:23:14.154112+00:00
- Polygon adjusted daily market bars · 2026-10-20T15:30:43.915212+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-20T15:30:43.912619+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-20. For educational purposes only; not investment advice.